Myasthenia Gravis: all 327 studies
Page 4 of 4. Open to participants first (144), then studies with results posted, then the rest; newest registration first within each.
- Innovative Measures of Speech and Swallowing Dysfunction in Neurological DisordersCompletedNCT02118805
- Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)TerminatedNCT02102594Phase 2
- Benefits and Tolerance of Exercise in Patients With Generalized and Stabilized Myasthenia GravisCompletedNCT02066519Not applicable
- Therapeutic Plasma Exchange in MGCompletedNCT01927692
- Subcutaneous Ig Maintenance Therapy for Myasthenia GravisTerminatedNCT01828294Phase 1
- The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand ThymectomyCompletedNCT01727193Phase 3
- A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia GravisStatus unknownNCT01555580Early Phase 1
- Perception and Multisensory Integration in Neurological Patients Using fMRIStatus unknownNCT01469858Not applicable
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisCompletedNCT01325571Phase 3
- Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia GravisTerminatedNCT01268280Phase 2
- Intravenous Immunoglobulin and Plasma Exchange in Myasthenia GravisCompletedNCT01179893Phase 4
- Study of an Intervention to Improve Problem List Accuracy and UseStatus unknownNCT01105923Not applicable
- The Role of the Thymus in Myasthenia GravisCompletedNCT01102192
- Exercise for Stable Myasthenia GravisStatus unknownNCT01047761Phase 1
- Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia GravisStatus unknownNCT00997412Not applicable
- Study Comparing Two Tapering Strategies of Prednisone in Myasthenia GravisCompletedNCT00987116Phase 4
- Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia GravisCompletedNCT00774462Phase 2
- Autologous Stem Cell Transplant for Neurologic Autoimmune DiseasesActive, not recruitingNCT00716066Phase 2
- A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia GravisCompletedNCT00683969Phase 3
- A Pilot Trial of Rituxan in Refractory Myasthenia GravisCompletedNCT00619671Phase 1/2
- Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia GravisCompletedNCT00515450Phase 3
- A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.CompletedNCT00408213Phase 3
- An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsCompletedNCT00309101Phase 3
- FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsCompletedNCT00309088Phase 3
- Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia GravisCompletedNCT00306033Phase 3
- Mycophenolate Mofetil in Myasthenia GravisCompletedNCT00285350Phase 3
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia GravisTerminatedNCT00004682Not applicable